Shared Care
Shared Care Protocols outline prescribing and monitoring responsibilities for the specialist and the GP.
Shared Care Protocols (SCPs) are used to allow prescribing to be taken on by a patient's GP once the patient is stable.
If you are a clinician and want to develop a shared care protocol please click here to contact us.
Below is a list of approved Shared Care Protocols:
- ADHD - atomoxetine information sheet (183 kb) Review date: April 2019
- ADHD - methylphenidate information sheet (154 kb) Review date: April 2019
- ADHD - overarching SCP (178 kb) Review date: April 2019
- Auto-immune Hepatitis- azathioprine information sheet (351 kb) Review date: Sep 2020
- Auto-immune Hepatitis- overarching SCP (47 kb) Review date: Sep 2020
- Dermatological conditions- azathioprine information sheet (248 kb) Review date: November 2020
- Dermatological conditions- methotrexate information sheet (240 kb) Review date: November 2020
- Dermatological conditions- overarching scp (167 kb) Review date: November 2020
- Dronedarone- information sheet (182 kb) Review date: Sept 2021
- Dronedarone- overarching SCP (182 kb) Review date: Sept 2021
- Growth hormone - information sheet (295 kb) Review date: Jan 2022
- Growth hormone - overarching SCP (181 kb) Review date: Jan 2022
- Inflammatory bowel disease - Azathioprine for children >12 years (251 kb) Review date: June 2022
- Inflammatory bowel disease - azathioprine information sheet (299 kb) Review date: Dec 2020
- Inflammatory bowel disease - mercaptopurine information sheet (298 kb) Review date: Dec 2020
- Inflammatory boweldisease - Methotrexate information sheet (208 kb) Review date: Dec 2020
- Inflammatory bowel disease - overarching SCP (175 kb) Review date: Dec 2019
- Neuroinflammatory conditions - azathioprine overarching SCP (223 kb) Review date: October 2020
- Neuroinflammatory conditions - azathioprine information sheet (227 kb) Review date: October 2020
- Neuroinflammatory conditions - azathioprine PIL (87 kb) Review date: October 2020
- Parkinson's disease - apomorphine information sheet (234 kb) Review date: Jan 2021
- Parkinson's disease - overarching SCP (265 kb) Review date: Jan 2021
- Phosphate binders for the treatment of hyperphosphataemia in adults (216 kb) Review date: September 2020
- Rheumatological conditions - azathioprine information sheet (224 kb) Review date: June 2020
- Rheumatological conditions - ciclosporin information sheet (272 kb) Review date: June 2020
- Rheumatological conditions - hydroxychloroquine information sheet (249 kb) Review date: June 2020
- Rheumatological conditions - injectable gold information sheet (218 kb) Review date: June 2020
- Rheumatological conditions - leflunomide information sheet (240 kb) Review date: June 2020
- Rheumatological conditions - methotrexate information sheet (235 kb) Review date: June 2020
- Rheumatological conditions - overarching SCP (127 kb) Review date: June 2020
- Rheumatological conditions - penicillamine information sheet (216 kb) Review date: June 2020
- Rheumatological conditions - sulphasalazine information sheet (228 kb) Review date: June 2020
- Rheumatology DMARDs Summary of Monitoring (155 kb) Review date: June 2019
- Riluzole for Motor Neurone Disease- Overarching SCP (37 kb) Review date: March 2021
- Riluzole for Motor Neurone Disease- Information Sheet (61 kb) Review date: March 2021
